2,4-thiazolidinedione has been researched along with Metabolic Diseases in 2 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burris, TP | 1 |
| Busby, SA | 1 |
| Griffin, PR | 1 |
| Currier, JS | 1 |
1 review available for 2,4-thiazolidinedione and Metabolic Diseases
| Article | Year |
|---|---|
Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.
Topics: Autoimmune Diseases; Humans; Metabolic Diseases; Orphan Nuclear Receptors; Phosphatidylcholines; PPA | 2012 |
1 other study available for 2,4-thiazolidinedione and Metabolic Diseases
| Article | Year |
|---|---|
How to manage metabolic complications of HIV therapy: what to do while we wait for answers.
Topics: Anabolic Agents; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Exercise Therapy; Gemfibro | 2000 |